HealthNet roadmap of the National Technology Initiative.
Excerpts from Dmitry Medvedev’s opening remarks:
Meeting of the Presidential Council for Economic Modernisation and Innovative Development Presidium
New medical technologies open up unique opportunities for humanity. Progress in genetics, biology and chemistry paved the way to what we call personalised medicine, which targets individual patients so that medical decisions are based on information about the health of a specific individual.
We are witnessing rapid growth of the market for all kinds of biological sensors, markers and telemedicine services enabling patients to undergo medical checkups online. IT development made it possible to accumulate and analyse big data, process it in the cloud and issue recommendations based on best practices.
Russia has also been active in its efforts to develop the medical equipment market. Compared to the situation some 10-12 years ago, a substantial range of medical equipment is made domestically. I am talking about big, complex and advanced devices.
We have to understand very clearly the path Russia must take to secure the place it deserves on all markets of medical services and equipment, so that we develop these technologies and improve our competence.
It is for answering these questions that the HealthNet roadmap was drafted as part of the National Technology Initiative.
Just as the National Technology Initiative in general, this is a forward-looking roadmap, focusing on emerging market niches. We must be in the centre of this development process, and place ourselves among its leaders. By 2035, at least five out of 70 leading global companies should be Russian. By this time, 70 percent of products and services should be fully localised, while Russia should be at the forefront in terms of producing and consuming them.
According to expert estimates, this market could reach $2 trillion by 2020 and $10 trillion within the next 20 years.
Russia has a number of advantages for gaining a solid foothold in this market. Primarily, our country has great research potential in medicine, biology, chemistry and mathematics, and we are committed to preserving it. We have solid training facilities, and the Sechenov University is one of them. Finally, Russia is strong in software development and IT.
The Russian healthcare system has benefited from important incentives recently, such as the creation of a system for providing modern high-technology medical aid. We are dealing with the drug safety issue, and new production facilities are being created. In this respect, the domestic pharmaceutical industry has achieved substantial results in recent years.
